PIK3CA and breast cancer: In the case of MCF7 cells, relatively low levels of phospho-AKT were detected (data not shown), consistent with previous studies showing that some luminal-type breast cancer cell lines, such as MCF7 cells, show weak activation of AKT signaling despite PIK3CA mutations; the authors speculated that this effect may be related to the function of another AKT regulator.